434 related articles for article (PubMed ID: 15688604)
1. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
Robert J
J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics and pharmacogenomics of cancers].
Robert J
Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376
[TBL] [Abstract][Full Text] [Related]
4. Cancer pharmacogenomics: international trends.
Yamayoshi Y; Iida E; Tanigawara Y
Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
[TBL] [Abstract][Full Text] [Related]
5. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
Goetz MP; Ames MM; Weinshilboum RM
Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
Huang Y
Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of cancer chemotherapy-induced toxicity.
Miller CR; McLeod HL
J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
11. Somatic pharmacogenomics in cancer.
Ikediobi ON
Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in pharmacogenomics in oncology].
Robert J; Bonnet J
Bull Cancer; 2004 Jan; 91(1):19-28. PubMed ID: 14975802
[TBL] [Abstract][Full Text] [Related]
13. Cancer pharmacogenomics: achievements in basic research.
Nakajima M; Yokoi T
Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
Yan L; Beckman RA
Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
[TBL] [Abstract][Full Text] [Related]
16. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.
Sauna ZE; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
Cancer Res; 2007 Oct; 67(20):9609-12. PubMed ID: 17942888
[TBL] [Abstract][Full Text] [Related]
17. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
Shai RM; Reichardt JK; Chen TC
Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
[TBL] [Abstract][Full Text] [Related]
19. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of importance for paclitaxel chemotherapy.
Green H
Pharmacogenomics; 2008 Jun; 9(6):671-4. PubMed ID: 18518845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
